CompletedNCT07055230

Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Rouen
Principal Investigator
Guillaume GM MAHAY, Doctor
University Rouen Hospital
Enrollment
67 enrolled
Eligibility
18 years · All sexes
Timeline
20222024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07055230 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials